In vitro suppression of bone marrow progenitor cell differentiation by human herpesvirus 6 infection

K K Knox1, D R Carrigan

  • 1Department of Pathology, Medical College of Wisconsin, Milwaukee 53226.

Insights

Human herpesvirus 6 (HHV-6) infection significantly impairs bone marrow function in transplant patients. Interferon-alpha neutralizing antibodies reversed these suppressive effects, suggesting a potential therapeutic target.

Area of Science:

  • Hematology
  • Virology
  • Immunology

Background:

  • Human herpesvirus 6 (HHV-6) infection is a serious complication in bone marrow transplant recipients.
  • Marrow suppression is a critical consequence of HHV-6 infection, impacting patient outcomes.

Purpose of the Study:

  • To investigate the in vitro effects of HHV-6 infection on normal bone marrow mononuclear cells.
  • To assess the impact of HHV-6 on hematopoietic stem and progenitor cell differentiation and proliferation.

Main Methods:

  • Infection of normal bone marrow mononuclear cells with HHV-6 in vitro.
  • Methylcellulose-based colony formation assay to evaluate progenitor cell growth.
  • Assessment of stromal layer outgrowth and viral presence in culture supernatants.

Main Results:

  • Significant inhibition of colony-forming units of granulocyte and macrophage lineages (cfu-GM) by 43%.
  • Marked reduction in granulocyte, erythrocyte, macrophage, and megakaryocyte lineages (cfu-GEMM) by 71%.
  • Substantial decrease in erythroid burst-forming unit (bfu-E) by 73% and marrow stromal layer by 74%.

Conclusions:

  • HHV-6 infection directly suppresses normal bone marrow hematopoietic progenitor cells and stromal cells in vitro.
  • Interferon-alpha plays a crucial role in mediating the suppressive effects of HHV-6 on bone marrow.
  • Neutralizing antibodies against interferon-alpha can reverse HHV-6-induced marrow suppression, indicating a potential therapeutic strategy.